Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions

A. Bourdin, L. Bjermer, C. Brightling, G. Brusselle, P. Chanez, F. Chung, A. Custovic, Z. Diamant, S. Diver, R. Djukanovic, D. Hamerlijnck, S. Johnston, F. Kanniess, N. Papadopoulos, A. Papi, R. Russell, D. Ryan, K. Samitas, T. Thomy, E. Zervas, M. Gaga
European Respiratory Journal 2019; DOI: 10.1183/13993003.00900-2019
A. Bourdin
1Service des Maladies Respirartoires, CHU Arnaud de Villeneuve, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Bjermer
2Department of Respiratory Medicine and Allergy, Lung and Allergy research Unit, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Brightling
3Department of Infection, Immunity and Inflammation, Institute for Lung Health, NIHR BRC Respiratory Medicine, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Brusselle
4Department of Respiratory Diseases, Ghent University Hospital, Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Chanez
5University of Marseille, Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Chung
6National Heart & Lung Institute, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Custovic
7Department of Paediatrics, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z. Diamant
8Dept of Respiratory Medicine & Allergology, Skane University Hospital, Lund, Sweden
9Respiratory and Allergy Research, QPS Netherlands, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Diver
1Service des Maladies Respirartoires, CHU Arnaud de Villeneuve, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Djukanovic
10University Hospital Southampton NHS Foundation Trust, Southampton, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Hamerlijnck
11Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D. Hamerlijnck
S. Johnston
12Department of Respiratory Medicine, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Kanniess
13Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Papadopoulos
1Service des Maladies Respirartoires, CHU Arnaud de Villeneuve, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Papi
14Respiratory Medicine, University of Ferrara, Ferrara, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Papi
R. Russell
15Institute for Lung Health, NIHR Leicester Biomedical Research Centre, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Ryan
16Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK
17Woodbrook Medical centre, Loughborough, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D. Ryan
K. Samitas
187th Resp. Med. Dept and Asthma Centre, Athens Chest Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Thomy
19Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Zervas
207th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E. Zervas
M. Gaga
217th Respiratory Medicine Department, Athens Chest Hospital Sotiria, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Gaga
  • For correspondence: minagaga@yahoo.com
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent a serious outcome such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial huge healthcare costs, and psychological burden including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a Task Force (TF) to search for a clear definition of severe exacerbations and to also define research questions and priorities. The statement includes comments from patients who were members of the TF.

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr. Bjermer has nothing to disclose.

Conflict of interest: Dr. Brightling reports grants and personal fees from GlaxoSmithKline, grants and personal fees from AstraZeneca/Medimmune, grants and personal fees from Novartis, grants and personal fees from Chiesi, grants and personal fees from Roche/Genentech, personal fees from Vectura, personal fees from Theravance, personal fees from PreP, personal fees from Gilead, personal fees from Sanofi/Regeneron, personal fees from Teva, grants from Pfizer, grants from Mologic, grants and personal fees from Boehringer-Inglheim, personal fees from Gossamer, personal fees from 4DPharma, outside the submitted work.

Conflict of interest: Dr. Brusselle reports personal fees from Astra Zeneca, personal fees from Boehringer-Ingelheim, personal fees from Chiesi, personal fees from Glaxo Smith Kline, personal fees from Novartis, personal fees from Sanofi, personal fees from Teva, outside the submitted work.

Conflict of interest: Dr. Chanez reports grants and personal fees from Almirall, grants and personal fees from BI, grants and personal fees from ALK, grants and personal fees from GSK, grants and personal fees from AstraZeneca, grants and personal fees from Novartis, grants and personal fees from Teva, grants and personal fees from Chiesi, outside the submitted work.

Conflict of interest: KFC has received honoraria for participating in Advisory Board meetings of GSK, AZ, Novartis, Merck, BI and TEVA regarding treatments for asthma and chronic obstructive pulmonary disease and has also been renumerated for speaking engagements.

Conflict of interest: Dr. Custovic reports personal fees from Novartis, personal fees from Regeneron/Sanofi, personal fees from Thermo Fisher Scientific, personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Philips, outside the submitted work.

Conflict of interest: Dr. Diamant reports personal fees from AstraZeneca, personal fees from Sanofi-Genzyme, during the conduct of the study; personal fees from Aquilon, personal fees from ALK, personal fees from Boehringer Ingelheim, personal fees from Gilead, personal fees from Hal Allergy, personal fees from MSD, outside the submitted work; and Apart from my academic affiliations I work at a phase I/II unit performing clinical studies for different biotech and pharma companies.

Conflict of interest: Dr. Diver has nothing to disclose.

Conflict of interest: Dr Djukanovic reports receiving fees for lectures at symposia organised by Novartis, AstraZeneca and TEVA, consultation for TEVA and Novartis as member of advisory boards, and participation in a scientific discussion about asthma organised by GlaxoSmithKline. He is a co-founder and current consultant, and has shares in Synairgen, a University of Southampton spin out company.

Conflict of interest: Dr. Hamerlijnck has nothing to disclose.

Conflict of interest: Dr. Kanniess reports personal fees from AstraZeneca, Novartis, Mundipharma, TEVA, outside the submitted work.

Conflict of interest: N. Papadopoulos

Conflict of interest: Dr. Papi reports grants, personal fees, non-financial support and other from AstraZeneca,, grants, personal fees, non-financial support and other from Boehringer Ingelheim, grants, personal fees, non-financial support and other from Chiesi Farmaceutici, grants, personal fees, non-financial support and other from GlaxoSmithKline, personal fees from Sanofi/Regeneron, personal fees and non-financial support from Zambon, grants, personal fees, non-financial support and other from Teva, personal fees and non-financial support from Novartis, personal fees, non-financial support and other from Mundipharma, personal fees and non-financial support from Almirall, grants, personal fees and non-financial support from Menarini, grants from Fondazione Maugeri, grants from Fondazione Chiesi Farmaceutici, outside the submitted work. Dr. Papi reports grants, personal fees, non-financial support and other from AstraZeneca, grants, personal fees, non-financial support and other from Boehringer Ingelheim, grants, personal fees, non-financial support and other from Chiesi Farmaceutici, grants, personal fees, non-financial support and other from GlaxoSmithKline, personal fees from Sanofi/Regeneron, personal fees and non-financial support from Zambon, grants, personal fees, non-financial support and other from Teva, personal fees and non-financial support from Novartis, personal fees, non-financial support and other from Mundipharma, personal fees and non-financial support from Almirall, grants, personal fees and non-financial support from Menarini, grants from Fondazione Maugeri, grants from Fondazione Chiesi Farmaceutici, outside the submitted work.

Conflict of interest: Dr. Russell has nothing to disclose.

Conflict of interest: Dr. Ryan reports personal fees from GSK, personal fees from Trudell Medical, personal fees from AZ, personal fees from Mylan, personal fees from Optimum Patient Care, personal fees from Chiesi, outside the submitted work.

Conflict of interest: Dr. SAMITAS has nothing to disclose.

Conflict of interest: T. Pomy

Conflict of interest: Dr. Gaga reports grants and personal fees from AZ, grants from BI, grants from Elpen, grants from Novartis, personal fees from BMS, personal fees from MSD, personal fees from Chiesi, grants from Menarini, personal fees from Pharmaten, outside the submitted work.

Conflict of interest: Dr. Tonia acts as ERS methodologist.

This is a PDF-only article. Please click on the PDF link above to read it.

  • Copyright ©ERS 2019
PreviousNext
Back to top
View this article with LENS
Vol 57 Issue 2 Table of Contents
European Respiratory Journal: 57 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions
A. Bourdin, L. Bjermer, C. Brightling, G. Brusselle, P. Chanez, F. Chung, A. Custovic, Z. Diamant, S. Diver, R. Djukanovic, D. Hamerlijnck, S. Johnston, F. Kanniess, N. Papadopoulos, A. Papi, R. Russell, D. Ryan, K. Samitas, T. Thomy, E. Zervas, M. Gaga
European Respiratory Journal Jan 2019, 1900900; DOI: 10.1183/13993003.00900-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions
A. Bourdin, L. Bjermer, C. Brightling, G. Brusselle, P. Chanez, F. Chung, A. Custovic, Z. Diamant, S. Diver, R. Djukanovic, D. Hamerlijnck, S. Johnston, F. Kanniess, N. Papadopoulos, A. Papi, R. Russell, D. Ryan, K. Samitas, T. Thomy, E. Zervas, M. Gaga
European Respiratory Journal Jan 2019, 1900900; DOI: 10.1183/13993003.00900-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
  • Imaging of pulmonary hypertension: Fleischner Society position paper
  • ERS Statement on Chronic Thromboembolic Pulmonary Hypertension
Show more Task force report

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society